Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase crucial for cell signaling.
• Aberrant EGFR activity and its complex conformational regulation are implicated in various cancers.
• Current therapeutic strategies often target the active EGFR conformation, but ligands stabilizing the inactive form offer alternative treatment avenues.

Purpose of the Study:

• To develop a direct binding assay for identifying novel ligands that stabilize the inactive conformation of EGFR.
• To explore new therapeutic strategies by targeting the inactive state of EGFR.

Main Methods:

• Development of a direct binding assay.
• Screening for ligands that specifically bind to the inactive conformation of EGFR.

Main Results:

• Successful development of a direct binding assay for EGFR inactive conformation.
• Identification of novel ligands capable of binding and stabilizing the inactive EGFR conformation.

Conclusions:

• The developed assay is effective in identifying ligands that target the inactive EGFR conformation.
• These findings pave the way for novel therapeutic strategies against cancers driven by dysregulated EGFR signaling.